Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Intramuscular Injections, Intravenous Injection
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
4950
Management System Certification
ISO9001:2015, ISO14001:2015, OHSAS18001:2007, GMP, GMP, GMP, GMP, GMP, GMP
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
  • Metoclopramide HCl Injection 2ml: 10mg GMP ISO Sfda Aproved
Find Similar Products

Basic Info.

Model NO.
2ml: 10mg
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Oral Liquid
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Packing
10ampoules/Tray, 10trays/Box, 20boxes/Carton
Transport Package
10ampouls/Tray/Box, 20boxes/Carton
Specification
2ml: 10mg
Trademark
Reyoung
Origin
China
HS Code
3004909099
Production Capacity
10000000000ampoules

Product Description

Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is an GMP, ISO9001, ISO14001, OHS18001 authentication enterprise and so on. The trademark "REYOUNG" is famous trademark of China.
Reyoung Pharma has three main factories which covers an area of 1,000,000 square meters and owns total asset of more than 1.5 billion USD dollar. There is more than 5000 staff in Reyoung Pharma, of whom approximate 21 percent of the total staff is sales & marketing personnel. Reyoung Pharma has 30 workshops that can produce ten categories and more than 400 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, traditional Chinese medicine and aerosol. The annual production capacity can reach 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules and 200 million bags granule of solid formulation, and 2000 tons API respectively. As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers all the big and medium cities through the mainland of PRC and also has been successfully covered more than 70 countries all over the world. In order to praise Reyoung Pharma making so much contribution to Chinese pharmaceutical industry, the government granted many awards and certifications, such as state-focused high & new tech enterprise of China, national contract-stressing and promise-keeping enterprise of China, the production base of cephalosporin raw material, advanced Collective of pharmaceutical industry of Shandong province and so on.
Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales&documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d′Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.
Look into the future, as entering into the market successively of the new products, the product structure of Reyoung Pharma will be upgraded, the producing levels and the market-controlling power will be enhanced further, and Reyoung Pharma will provide a wider platform for our old and new friends to go hand in hand and seek common development.
Reyoung Dana  Liu
Contact 18353318519

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier